Simple Summary Therapeutic vaccines are given to patients with cancer, as opposed to
prophylactic vaccines given to a healthy population. The challenge for therapeutic …

Objectives This systematic review provides an overview of the current clinical trials
investigating therapeutic vaccines for HPV+ head and neck cancer and discusses the future …

Therapeutic vaccination is one of the most effective immunotherapeutic approaches, second
only to immune checkpoint inhibitors (ICIs), which have already been approved for clinical …

Head and neck cancer represents one of the most challenging diseases as the mortality
remains high despite advances in early diagnosis and treatment. Human papillomavirus has …

Background Globally, head and neck squamous cell carcinoma (HNSCC) is the seventh
most common malignancy. Despite aggressive multimodal treatment approaches, recurrent …

Abstract Purpose of Review The goal of this narrative review is to educate clinicians
regarding the foundational concepts, efficacy, and future directions of therapeutic vaccines …

Recent data demonstrate that human papilloma virus (HPV) plays a role in pathologies other
than ano-genital cancers, specifically head and neck malignancies, and non-cancerous …

Human papillomavirus (HPV) is widely known as a cause of cervical cancer (CC) and
cervical intraepithelial neoplasia (CIN). HPVs related to cancer express two main …

Immune therapies aiming at the destruction of a residual tumor and inducing tumor-specific
memory responses are gaining acceptance among clinicians treating head and neck …

The rise in human papillomavirus (HPV)-associated oropharyngeal squamous cell
carcinoma (OPSCC) has prompted a quest for further understanding of the role of high-risk …